Pub Date : 2023-06-30DOI: 10.1097/01.PGO.0000937004.49421.0f
Olivia Chafitz, Anat Chemerinski, P. McGovern
on a random sample of 335 women aged 25 to 40 years.1 Contrastingly, 2 large cancer screening studies evaluated asymptomatic women over the age of 50 and 55 years, and reported prevalence rates of 18% and 14.1%, respectively.2,3 An important consideration in the evaluation of adnexal masses is the exclusion of malignancy.4 Given the low risk of malignancy and high rate of spontaneous resolution, interval surveillance is typically the recommended management for simple ovarian cysts.
{"title":"Management of Simple Ovarian Cysts","authors":"Olivia Chafitz, Anat Chemerinski, P. McGovern","doi":"10.1097/01.PGO.0000937004.49421.0f","DOIUrl":"https://doi.org/10.1097/01.PGO.0000937004.49421.0f","url":null,"abstract":"on a random sample of 335 women aged 25 to 40 years.1 Contrastingly, 2 large cancer screening studies evaluated asymptomatic women over the age of 50 and 55 years, and reported prevalence rates of 18% and 14.1%, respectively.2,3 An important consideration in the evaluation of adnexal masses is the exclusion of malignancy.4 Given the low risk of malignancy and high rate of spontaneous resolution, interval surveillance is typically the recommended management for simple ovarian cysts.","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129532985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on May 14, 2025.
Lippincott继续医学教育研究所(Lippincott Continuing Medical Education Institute, Inc.)将这种持久材料指定为最高2.0 AMA PRA第1类信用标准。医生只应主张与其参与活动的程度相称的功劳。要获得CME学分，您必须阅读CME文章并完成随附答题表上的测试和评估，正确回答10个测试问题中的至少7个。CME活动将于2025年5月14日到期。
{"title":"Antibiotic Stewardship and Intrapartum Fever","authors":"Audrey Marinelli, Lauren Benedetto, Hannah Hughes Ehasz","doi":"10.1097/01.PGO.0000927168.41776.93","DOIUrl":"https://doi.org/10.1097/01.PGO.0000927168.41776.93","url":null,"abstract":"Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on May 14, 2025.","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128324351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-04-30DOI: 10.1097/01.PGO.0000924208.59373.f6
F. DiBiase, D. Burrell, H. Smith
, such as the ovary, abdomen, or cervix. Fewer than 10% of all ectopic pregnancies occur outside the fallopian tube, but these ectopic pregnancies contribute more significantly to A 30-year-old gravida 3 para 2002 woman at 5 weeks estimated gestational age by her last menstrual period presents to the emergency department with mild cramping and vaginal bleeding. Examination demonstrates a small amount of dark red bleeding and mild, diffuse tenderness to palpa-tion over bilateral lower abdominal quadrants. Her vital signs are normal. Laboratory workup is unremarkable, consistent with pregnancy with a beta-human chorionic gonadotropin ( β hCG) value of 3700 IU/L. She is Rh positive. Ultrasound shows a yolk sac consistent with gestational age in the lower portion of the uterus, near the cervix (Figure 1). Most obstetrician-gynecologists have cared for
{"title":"Cervical Ectopic and Cesarean Scar Pregnancies: Navigating the Differential of an Abnormal Lower Uterine Pregnancy","authors":"F. DiBiase, D. Burrell, H. Smith","doi":"10.1097/01.PGO.0000924208.59373.f6","DOIUrl":"https://doi.org/10.1097/01.PGO.0000924208.59373.f6","url":null,"abstract":", such as the ovary, abdomen, or cervix. Fewer than 10% of all ectopic pregnancies occur outside the fallopian tube, but these ectopic pregnancies contribute more significantly to A 30-year-old gravida 3 para 2002 woman at 5 weeks estimated gestational age by her last menstrual period presents to the emergency department with mild cramping and vaginal bleeding. Examination demonstrates a small amount of dark red bleeding and mild, diffuse tenderness to palpa-tion over bilateral lower abdominal quadrants. Her vital signs are normal. Laboratory workup is unremarkable, consistent with pregnancy with a beta-human chorionic gonadotropin ( β hCG) value of 3700 IU/L. She is Rh positive. Ultrasound shows a yolk sac consistent with gestational age in the lower portion of the uterus, near the cervix (Figure 1). Most obstetrician-gynecologists have cared for","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128247534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-31DOI: 10.1097/01.PGO.0000921332.43236.fc
Miriam R. Raffeld, Avita K. Pahwa, C. Glowacki
5-10 Given these new data, a focus on alternative oral medication treatments has emerged, including use of selective M2/M3 antagonists such as trospium and β -3 adrenergic agonists mirabegron and vibegron. 11-13 The American Geriatrics Society recently updated the Beers Criteria to include anticholinergic medications as a risk Overactive bladder (OAB) is a symptomatic condition characterized by urinary urgency, with or without incontinence, and is often associated with nocturia and increased frequency. 1 OAB is highly prevalent in the US adult population, affecting women and men similarly (16.9% and 16%, respectively). The prevalence of symptom type and severity, however, significantly differs by sex, with women noting urgency incontinence more frequently than men: 19.1% in women aged 65 to 74 years and 8.2% in men aged 65 to 74 years. 2 In women older than 65 years, the prevalence of OAB increases from 16% to 30%. 3 The hallmark physiologic abnormality responsible for OAB is detrusor overac-VOLUME
{"title":"Overactive Bladder Management: Cognitive Risk With Anticholinergics and Alternative Management Options for the General Practitioner","authors":"Miriam R. Raffeld, Avita K. Pahwa, C. Glowacki","doi":"10.1097/01.PGO.0000921332.43236.fc","DOIUrl":"https://doi.org/10.1097/01.PGO.0000921332.43236.fc","url":null,"abstract":"5-10 Given these new data, a focus on alternative oral medication treatments has emerged, including use of selective M2/M3 antagonists such as trospium and β -3 adrenergic agonists mirabegron and vibegron. 11-13 The American Geriatrics Society recently updated the Beers Criteria to include anticholinergic medications as a risk Overactive bladder (OAB) is a symptomatic condition characterized by urinary urgency, with or without incontinence, and is often associated with nocturia and increased frequency. 1 OAB is highly prevalent in the US adult population, affecting women and men similarly (16.9% and 16%, respectively). The prevalence of symptom type and severity, however, significantly differs by sex, with women noting urgency incontinence more frequently than men: 19.1% in women aged 65 to 74 years and 8.2% in men aged 65 to 74 years. 2 In women older than 65 years, the prevalence of OAB increases from 16% to 30%. 3 The hallmark physiologic abnormality responsible for OAB is detrusor overac-VOLUME","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"22 13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123420544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-03-15DOI: 10.1097/01.pgo.0000920232.40375.8b
J. Shinnick, N. Korbly
tract,
束,
{"title":"Treatment and Prevention of Recurrent Urinary Tract Infections for the Obstetrician/Gynecologist","authors":"J. Shinnick, N. Korbly","doi":"10.1097/01.pgo.0000920232.40375.8b","DOIUrl":"https://doi.org/10.1097/01.pgo.0000920232.40375.8b","url":null,"abstract":"tract,","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116425422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-02-28DOI: 10.1097/01.PGO.0000919116.97611.fb
Francesca Yi, A. French
Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on February 27, 2025.
Lippincott继续医学教育研究所(Lippincott Continuing Medical Education Institute, Inc.)将这种持久材料指定为最高2.0 AMA PRA第1类信用标准。医生只应主张与其参与活动的程度相称的功劳。要获得CME学分，您必须阅读CME文章并完成随附答题表上的测试和评估，正确回答10个测试问题中的至少7个。CME活动将于2025年2月27日到期。
{"title":"Evaluation and Management of Heavy Menstrual Bleeding in Adolescents","authors":"Francesca Yi, A. French","doi":"10.1097/01.PGO.0000919116.97611.fb","DOIUrl":"https://doi.org/10.1097/01.PGO.0000919116.97611.fb","url":null,"abstract":"Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on February 27, 2025.","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130336432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-15DOI: 10.1097/01.PGO.0000905060.98021.c3
Kaitlin Demarest, Ryan H. Sobel
average of 5 health care providers before even receiving a diagnosis. 5 Based on studies in the United States, at least 16% of women suffer from vulvodynia. 2 There is a substantial economic burden due to costs of medical care, medications and other therapy, and time missed from work. A study by Xie et al 6 estimated the annual cost of vulvodynia to be $31 billion to 72 billion in the United States. Vulvodynia is defined as vulvar pain lasting at least 3 months without a clear identifiable cause but potential associated factors. This definition is a result of a multisocietal (International Society for the Study of Vulvovaginal Disease, International Society for the Study of Women’s Sexual Health, and International Pelvic Pain Society [IPPS]) consensus published in 2015. 1 As it has been studied over time, this condition has also been referred to as “vulvar dysesthe-sia,” “vulvar vestibulitis,” and “vestibulodynia.” 1,2 Patients with vulvodynia may experience vulvovestibular burning, stinging, itching, irritation, tenderness, or any combination of these. 2 The 2015 consensus guidelines for vulvodynia
{"title":"Topical Therapy for Vulvodynia: A Review of the Literature","authors":"Kaitlin Demarest, Ryan H. Sobel","doi":"10.1097/01.PGO.0000905060.98021.c3","DOIUrl":"https://doi.org/10.1097/01.PGO.0000905060.98021.c3","url":null,"abstract":"average of 5 health care providers before even receiving a diagnosis. 5 Based on studies in the United States, at least 16% of women suffer from vulvodynia. 2 There is a substantial economic burden due to costs of medical care, medications and other therapy, and time missed from work. A study by Xie et al 6 estimated the annual cost of vulvodynia to be $31 billion to 72 billion in the United States. Vulvodynia is defined as vulvar pain lasting at least 3 months without a clear identifiable cause but potential associated factors. This definition is a result of a multisocietal (International Society for the Study of Vulvovaginal Disease, International Society for the Study of Women’s Sexual Health, and International Pelvic Pain Society [IPPS]) consensus published in 2015. 1 As it has been studied over time, this condition has also been referred to as “vulvar dysesthe-sia,” “vulvar vestibulitis,” and “vestibulodynia.” 1,2 Patients with vulvodynia may experience vulvovestibular burning, stinging, itching, irritation, tenderness, or any combination of these. 2 The 2015 consensus guidelines for vulvodynia","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"303 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121467532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-31DOI: 10.1097/01.PGO.0000904320.61363.82
Simone Reaves, R. Ross, K. Echols
regimens for prevention and treatment. Proper diagnosis of rUTI and potential therapies are reviewed in this article. UTIs impact a large number of women regardless of age, race, or socioeconomic level. UTIs are responsible for approximately 3.6 million office visits per year, and cost nearly $2 billion in health care. 1 Over 50% of women are diagnosed with a UTI in their lifetime. Infections are based on the presence of a lower and/or upper urinary tract pathogen without underlying Urinary tract infection (UTI) is the most common type of bacterial infection, affecting more than 50% to 60% of women of all racial and socioeconomic backgrounds. Of those women experiencing UTI, 30% will have recurrent episodes causing significant morbidity, reduced quality of life, and health care costs totaling billions of dollars. 1 Accurate diagnosis continues to evolve based on emerging information of the intravesical microbiome. The American Urologic Association has current recommendations for the diagnosis of recurrent UTI (rUTI). Urinalysis (UA) and culture are not always necessary for simple cystitis, but UA and culture with sensitivities before initiating antibiotic Learning Objectives: After participating in this continuing education activity, the provider should be better able to: a treatment plan, appropriate antibiotic integrative
{"title":"An Integrative Approach to Recurrent Urinary Tract Infections for the Obstetrician and Gynecologist","authors":"Simone Reaves, R. Ross, K. Echols","doi":"10.1097/01.PGO.0000904320.61363.82","DOIUrl":"https://doi.org/10.1097/01.PGO.0000904320.61363.82","url":null,"abstract":"regimens for prevention and treatment. Proper diagnosis of rUTI and potential therapies are reviewed in this article. UTIs impact a large number of women regardless of age, race, or socioeconomic level. UTIs are responsible for approximately 3.6 million office visits per year, and cost nearly $2 billion in health care. 1 Over 50% of women are diagnosed with a UTI in their lifetime. Infections are based on the presence of a lower and/or upper urinary tract pathogen without underlying Urinary tract infection (UTI) is the most common type of bacterial infection, affecting more than 50% to 60% of women of all racial and socioeconomic backgrounds. Of those women experiencing UTI, 30% will have recurrent episodes causing significant morbidity, reduced quality of life, and health care costs totaling billions of dollars. 1 Accurate diagnosis continues to evolve based on emerging information of the intravesical microbiome. The American Urologic Association has current recommendations for the diagnosis of recurrent UTI (rUTI). Urinalysis (UA) and culture are not always necessary for simple cystitis, but UA and culture with sensitivities before initiating antibiotic Learning Objectives: After participating in this continuing education activity, the provider should be better able to: a treatment plan, appropriate antibiotic integrative","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124700367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-30DOI: 10.1097/01.PGO.0000892912.67238.28
A. Whelan, Amber Young, Martha B. Kole-White
{"title":"Eclampsia: The Essentials for Obstetricians and Gynecologists","authors":"A. Whelan, Amber Young, Martha B. Kole-White","doi":"10.1097/01.PGO.0000892912.67238.28","DOIUrl":"https://doi.org/10.1097/01.PGO.0000892912.67238.28","url":null,"abstract":"","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125607118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-31DOI: 10.1097/01.PGO.0000884780.20913.9c
Rose C. Mahoney, Margaret M. Thorsen, M. Russo
Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on October 30, 2024.
{"title":"Prenatal Diagnosis: Procedures and Genetic Testing Methods","authors":"Rose C. Mahoney, Margaret M. Thorsen, M. Russo","doi":"10.1097/01.PGO.0000884780.20913.9c","DOIUrl":"https://doi.org/10.1097/01.PGO.0000884780.20913.9c","url":null,"abstract":"Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This CME activity expires on October 30, 2024.","PeriodicalId":193089,"journal":{"name":"Topics in Obstetrics & Gynecology","volume":"33 4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126195257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：